Drug class in one race
PI3K-delta drugs for Non-Small Cell Lung Cancer
2 tracked PI3K-delta drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PI3K-delta page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
2 Phase 1/2